Takahashi, Masato
Tokunaga, Eriko
Mori, Joji
Tanizawa, Yoshinori
van der Walt, Jan-Stefan
Kawaguchi, Tsutomu
Goetz, Matthew P.
Toi, Masakazu http://orcid.org/0000-0003-1488-9958
Clinical trials referenced in this document:
Documents that mention this clinical trial
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
https://doi.org/10.1007/s12282-021-01295-0
Funding for this research was provided by:
eli lilly japan
Article History
Received: 2 August 2021
Accepted: 13 September 2021
First Online: 18 October 2021
Declarations
:
: Masato Takahashi reports personal fees from AstraZeneca, Eisai Co., Ltd., Eli Lilly and Company, and Pfizer. Eriko Tokunaga reports personal fees from AstraZeneca, Chugai Pharmaceutical Co., Ltd., and Eli Lilly and Company. Matthew P. Goetz reports fees to research institute from AstraZeneca, Biotheranostics, Biovica, Blueprint Medicines, Eagle Pharmaceuticals, Eli Lilly and Company, Novartis, Pfizer, and Sermonix; grants to research institute from Eli Lilly and Company, Pfizer, and Sermonix; and personal fees from Research to Practice and Clinical Education Alliance. Masakazu Toi reports personal fees and grants from AstraZeneca<i>,</i> Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co. Ltd, Eisai Co., Ltd., Kyowa Kirin Co. Ltd., Nippon Kayaku, Pfizer, Shimadzu, Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Ltd., and Yakult; personal fees from Eli Lilly and Company, Exact Science, Konica Minolta, Inc., MSD, and Novartis; grants from AFI Technologies, Astellas Pharma, Inc., the Japanese Breast Cancer Research Group Association, Luxonus, Inc., and Shionogi; membership on advisory boards for Athenex Oncology, BMS, Daiichi Sankyo Co. Ltd, Eli Lilly and Company, Konica Minolta, Inc., and Kyowa Kirin Co. Ltd.; and membership on the Board of Directors of the Japanese Breast Cancer Research Group Association, Organisation for Oncology and Translational Research, and Kyoto Breast Cancer Research Network. Joji Mori, Tsutomu Kawaguchi, and Yoshinori Tanizawa are employees and minor shareholders of Eli Lilly Japan K.K. Jan-Stefan van der Walt is an employee and minor shareholder of Eli Lilly and Company, UK.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.